510(k) Report

510(k) · Cleared

Recalled · 2006

Asahi AM-Bio Series Dialyzers (Wet Models)& (Dry Models), Models AM-Bio-50,AM-Bio-65, AM-Bio-75, and AM-Bio-100, AM-Bio-

K983720510(k) TraditionalCleared May 17, 1999208-day reviewClass II21 CFR 876.5820Recalls 3

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Asahi Medical Co., Ltd. · MSE Hemodialyzer, Re-Use, Low Flux

Cleared on May 17, 1999 after a 208-day review. The FDA summary names its predicate without a number. 1 later device descends from it. It has been recalled 3 times.

Decided
May 17, 1999
Review
208 days
Class
Class II
Product code
MSE
Recalls
3
Predicates
0

1 later device descends from it, 1 citing it directly.

Descendants, by year cleared 2002: 1 descendant cleared1995200020052010201520202025
  1. This deviceK983720 Asahi AM-Bio Series Dialyzers (Wet Models)& (Dry Models), Models…Asahi Medical Co., Ltd. · 1999
  2. Descendant · cites it directly · 0 of its ownK013418 AM-Bio Extended Range Series Dialyzer, Models Wet and DryAsahi Medical Co., Ltd. · 2002 · Recalled

Most influential descendants

Showing 1 of 1 · See all
  • K013418AM-Bio Extended Range Series Dialyzer, Models Wet and DryAsahi Medical Co., Ltd. · 2002 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K983720Asahi AM-Bio Series Dialyzers (Wet Models)& (Dry Models), Models…Asahi Medical Co., Ltd.1999—
+1K013418AM-Bio Extended Range Series Dialyzer, Models Wet and DryAsahi Medical Co., Ltd.20021

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200210
FIG. 1 — Lineage of K983720, 1999–2002Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MSE? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (5)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*—Asahi AM Series Dialyzers
Named without a submission number
—
*—Asahi AM-R Series Dialyzers
Named without a submission number
—
*—Baxter HT Dialyzers
Named without a submission number
—
*—Gambro COBE Centrysystem HG Dialyzers
Named without a submission number
—
*—Gambro Alwall GFS Plus Dialyzers
Named without a submission number
—

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K013418AM-Bio Extended Range Series Dialyzer, Models Wet and DryAsahi Medical Co., Ltd.20020

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Oct 12, 2006Not classifiedZ-0174-2007OtherThere have been reports of difficulty separating the Gambro Cartridge Blood Set from Asahi Reuse/Multiple Use Dialyzers at the end of treatment, possibly damaging the dialyzer nozzle.
Oct 12, 2006Not classifiedZ-0173-2007OtherThere have been reports of difficulty separating the Gambro Cartridge Blood Set from Asahi Reuse/Multiple Use Dialyzers at the end of treatment, possibly damaging the dialyzer nozzle.
Mar 31, 2005Not classifiedZ-0788-05OtherExposure to freezing temperatures may damage the hollow fiber dialyzers and result in blood leaks during dialysis.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K013418 (Asahi Medical Co., Ltd., 2002) has gone furthest, with 0 descendants of its own.

How does its category compare?

All MSE devices

MSE Hemodialyzer, Re-Use, Low Flux: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · MSE

FDA has decided no MSE device since 2007.

Median 510(k) review, days · MSE

Too few MSE 510(k)s in any year since 2007 to give a median.

Recalls per year · MSE

No recall names MSE since 2007.

Adverse event reports per year · MSE

5in 2014

2010: 62011: 52014: 5
2007high 6 (2010) · low 0 (2007)2025

MAUDE reports naming product code MSE, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—06
20110—05
20120—00
20130—00
20140—05
20150—00
20160—00
20170—00
20180—00
20190—00
20200—00
20210—00
20220—00
20230—00
20240—00
20250—00
20260—0—

What is it indicated for?

a. Asahi AM-BIO Series Dialyzers are intended for use for hemodialysts treatment of patients who have chronic renal failure or acute renal failure, b. Asshi AM-BIO Series Dialyzers must be used in accordance with the instructions of a physician familiar with hemodialysis and familiar with the conditions of the patient. c. Asahi AM-BIO Series-Dialyzers have been tested in vitro and in confirmatory clinical studies under single or initial use and under…

Read the full statement (327 words)

a. Asahi AM-BIO Series Dialyzers are intended for use for hemodialysts treatment of

patients who have chronic renal failure or acute renal failure,

b. Asshi AM-BIO Series Dialyzers must be used in accordance with the instructions of a

physician familiar with hemodialysis and familiar with the conditions of the patient.

c. Asahi AM-BIO Series-Dialyzers have been tested in vitro and in confirmatory clinical

studies under single or initial use and under reprocessing and reuse conditions for up to 13

reuse cycles. Based on the resuits from these evaluations, Asahi AM-BJO Series

Dialyzers may be reprocessed for reuse on the same patient. If reprocessing and reuse is

practiced, it is recommended that the reuse be done under the conditions as existed in the

in vitro and confirmatory clinical studies as recommended immediately below. It is noted

that the Asahi AM-BIO Series Dialyzers have not been tested for reuse when reprocessed

with agents and/or processes other than these, and the performance of the dialyzers under

other conditions are not known and cannot be recommended. Accordingly:

The reprocessed dialyzer may be used only if the residual Total Cell Volume

{TCV) is at least 80% of the original TCV and if such dialyzer otherwise meets

the acceptance criteria of these instructions for use and the instructions of the

reprocessing system utilized. Furthermore, the policies, instructions, and criteria

of the institution for reuse (e.g., conceming dialyzer performance, residual blood,

and/or dialyzer leakage or damage) should be followed.

The reprocessing agent may be either (1) 4% formaldehyde (also known as

formalin) in conjunction with the Seratronics Dialyzer Reprocessing Systems for

Dialyzer Reprocessing and Preparation (DRS4" and DPS4 ), manufactured by

Seratronics, Inc., or (2) Renalin® in conjunction with the Renatron® Dialvzer

Reprocessing System (RS 8300), manufactured by Renal Systems, Inc.

The instructions provided by the manufacturer of the chosen reprocessing agent

must be followed in reprocessing the dialyzer.

The reprocessed dialyzer may be used only on dialysis systems equipped with

volumetric ultrafiitration controllets.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K983720: Asahi AM-Bio Series Dialyzers (Wet Models)& (Dry Models), Models AM-Bio-50,AM-Bio-65, AM-Bio-75, and AM-Bio-100, AM-Bio-.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K983720

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026